Myovant Sciences rejects $2.5 billion takeover bid from Sumitovant, Sumitomo Pharma EP News Bureau Oct 3, 2022 Sumitovant, which currently holds approximately 52 per cent of the outstanding shares in Myovant Sciences, and Sumitomo Pharma,…
